Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Journal of Experimental & Clinical Cancer Research : CR
|
February 15, 2003
Usefulness of breast MRI in a patient with genetic risk
L Cortesi, B Canossi, M De Santis, et al.
Andrologia
|
September 17, 2005
Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue
S De Stefani, V Silingardi, S Micali, et al.
Haematologica
|
September 1, 1993
Epidoxorubicin vs idarubicin containing regimens in intermediate and high grade non-Hodgkin's lymphoma: preliminary results of a multicentric randomized trial
M Brugiatelli, M Federico, P G Gobbi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer
A Contegiacomo, M Pensabene, I Capuano, et al.
Haematologica
|
November 24, 1998
Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL
M Federico, V Clò, M Brugiatelli, et al.
Haematologica
|
November 1, 1996
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL)
P G Gobbi, C Pieresca, L Cavanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: the Gruppo Italiano per lo Studio dei Linfomi Experience
P G Gobbi, C Pieresca, A Frassoldati, et al.
Haematologica
|
February 22, 2000
Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry
C Stelitano, L Baldini, C Pieresca, et al.
Minerva Medica
|
November 3, 1979
[Clinico-immunological study of 6 cases of Behçet's disease]
V Silingardi, C Montemurno, L Venezia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2005
Comment on 'Cancer genetic counselling' by P. Mandich et al. (Ann Oncol 2005; 16: 171)
A Contegiacomo, M Pensabene, I Capuano, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Journal of Experimental & Clinical Cancer Research : CR
|
February 15, 2003
Usefulness of breast MRI in a patient with genetic risk
L Cortesi, B Canossi, M De Santis, et al.
Andrologia
|
September 17, 2005
Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue
S De Stefani, V Silingardi, S Micali, et al.
Haematologica
|
September 1, 1993
Epidoxorubicin vs idarubicin containing regimens in intermediate and high grade non-Hodgkin's lymphoma: preliminary results of a multicentric randomized trial
M Brugiatelli, M Federico, P G Gobbi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer
A Contegiacomo, M Pensabene, I Capuano, et al.
Haematologica
|
November 24, 1998
Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL
M Federico, V Clò, M Brugiatelli, et al.
Haematologica
|
November 1, 1996
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL)
P G Gobbi, C Pieresca, L Cavanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: the Gruppo Italiano per lo Studio dei Linfomi Experience
P G Gobbi, C Pieresca, A Frassoldati, et al.
Haematologica
|
February 22, 2000
Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry
C Stelitano, L Baldini, C Pieresca, et al.
Minerva Medica
|
November 3, 1979
[Clinico-immunological study of 6 cases of Behçet's disease]
V Silingardi, C Montemurno, L Venezia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2005
Comment on 'Cancer genetic counselling' by P. Mandich et al. (Ann Oncol 2005; 16: 171)
A Contegiacomo, M Pensabene, I Capuano, et al.
Page
of 8